P257 Ivacaftor therapy on cystic fibrosis transmembrane conductance regulator function is evaluated in a patient with 3849 + 10kbC > T mutation.

MLA

Yu, Y., et al. “P257 Ivacaftor Therapy on Cystic Fibrosis Transmembrane Conductance Regulator Function Is Evaluated in a Patient with 3849 + 10kbC > T Mutation.” Journal of Cystic Fibrosis, vol. 18, June 2019, p. S129. EBSCOhost, https://doi.org/10.1016/S1569-1993(19)30550-8.

APA

Yu, Y., Stahl, M., Hirtz, S., Salomon, J., Mairbäurl, H., & Sommerburg, O. (2019). P257 Ivacaftor therapy on cystic fibrosis transmembrane conductance regulator function is evaluated in a patient with 3849 + 10kbC > T mutation. Journal of Cystic Fibrosis, 18, S129. https://doi.org/10.1016/S1569-1993(19)30550-8

Chicago

Yu, Y., M. Stahl, S. Hirtz, J. Salomon, H. Mairbäurl, and O. Sommerburg. 2019. “P257 Ivacaftor Therapy on Cystic Fibrosis Transmembrane Conductance Regulator Function Is Evaluated in a Patient with 3849 + 10kbC > T Mutation.” Journal of Cystic Fibrosis 18 (June): S129. doi:10.1016/S1569-1993(19)30550-8.